 |
 |

PRESENT STATUS OF PLASMA VOLUME EXPANDERS IN THE TREATMENT OF SHOCKClinical Laboratory Studies
WALTER L. BLOOM, M.D.
AMA Arch Surg. 1951;63(6):739-741.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
SINCE many will find the investigative approach of our group somewhat unusual, I shall first attempt to elucidate the factors necessitating the procedure which we have followed. At the time we started our study on plasma volume expansion, certain unquestionable facts had been established. The first was that shock was frequently associated with decreased plasma volume and the second was that any substance which would expand and maintain plasma volume would often bring about relief of shock. The third established fact was the practical consideration that most of the substance used previously resulted in storage of the material in the body or in functional impairment of one or more organs.
To reach a solution in this problem it was necessary to find a substance which was capable of remaining in the blood stream, maintaining the vascular volume, and eventually being excreted or metabolized. Glycogen appeared to answer our demands, and
. . . [Full Text PDF of this Article]
Author Affiliations
ATLANTA, GA.
Footnotes
Read before the Section on Anesthesiology as part of a symposium on Plasma Volume Expanders in the Treatment of Shock at the One-Hundredth Annual Session of the American Medical Association, Atlantic City, June 13, 1951.
The data reported in this paper are the results of the efforts of a team of investigators of which the author was the responsible investigator on a contract from the United States Army. Detailed discussion of the individual problems in the paper will be presented elsewhere.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|